To understand the effect that loss of IL-6 in the tumor microenvironment has on leukemia response to chemotherapy in B-ALL, we transplanted leukemia cells into syngeneic IL-6 KO mice17 and treated these mice with doxorubicin. The gene discussed is IL6; the disease is neoplasm.